BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8712167)

  • 1. Prevention of transfusion-associated cytomegalovirus infection. Practice parameter. American Society of Clinical Pathologists.
    Przepiorka D; LeParc GF; Werch J; Lichtiger B
    Am J Clin Pathol; 1996 Aug; 106(2):163-9. PubMed ID: 8712167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).
    Cherry AM; Akkari YM; Barr KM; Kearney HM; Rose NC; South ST; Tepperberg JH; Meck JM
    Genet Med; 2017 Aug; 19(8):845-850. PubMed ID: 28726804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
    Stewart DR; Korf BR; Nathanson KL; Stevenson DA; Yohay K
    Genet Med; 2018 Jul; 20(7):671-682. PubMed ID: 30006586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
    Gregg AR; Skotko BG; Benkendorf JL; Monaghan KG; Bajaj K; Best RG; Klugman S; Watson MS
    Genet Med; 2016 Oct; 18(10):1056-65. PubMed ID: 27467454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).
    Pasquali M; Yu C; Coffee B
    Genet Med; 2018 Jan; 20(1):3-11. PubMed ID: 29261178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X syndrome: diagnostic and carrier testing.
    Sherman S; Pletcher BA; Driscoll DA
    Genet Med; 2005 Oct; 7(8):584-7. PubMed ID: 16247297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.
    Strovel ET; Cowan TM; Scott AI; Wolf B
    Genet Med; 2017 Oct; 19(10):. PubMed ID: 28682309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population.
    Monaghan KG; Feldman GL; Palomaki GE; Spector EB; ;
    Genet Med; 2008 Jan; 10(1):57-72. PubMed ID: 18197058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier screening in individuals of Ashkenazi Jewish descent.
    Gross SJ; Pletcher BA; Monaghan KG;
    Genet Med; 2008 Jan; 10(1):54-6. PubMed ID: 18197057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Section E6.5-6.8 of the ACMG technical standards and guidelines: chromosome studies of lymph node and solid tumor-acquired chromosomal abnormalities.
    Cooley LD; Morton CC; Sanger WG; Saxe DF; Mikhail FM
    Genet Med; 2016 Jun; 18(6):643-8. PubMed ID: 27124786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acylcarnitine profile analysis.
    Rinaldo P; Cowan TM; Matern D
    Genet Med; 2008 Feb; 10(2):151-6. PubMed ID: 18281923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation.
    Shaffer LG;
    Genet Med; 2005; 7(9):650-4. PubMed ID: 16301868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities.
    Mikhail FM; Heerema NA; Rao KW; Burnside RD; Cherry AM; Cooley LD
    Genet Med; 2016 Jun; 18(6):635-42. PubMed ID: 27124785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics.
    ACMG Board of Directors
    Genet Med; 2016 Feb; 18(2):207-8. PubMed ID: 26681314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing in clinical genetics: points to consider-a statement of the American College of Medical Genetics and Genomics.
    Acmg Board Of Directors
    Genet Med; 2017 Jul; 19(7):723-724. PubMed ID: 28125080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations in healthcare reform for patients and families with genetic diseases: a statement of the American College of Medical Genetics and Genomics.
    Genet Med; 2018 Jun; 20(6):561. PubMed ID: 29388944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
    Fraser GA; Walker II;
    Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics.
    Acmg Board Of Directors
    Genet Med; 2017 Jul; 19(7):721-722. PubMed ID: 28055021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening?
    Preiksaitis JK
    Transfus Med Rev; 2000 Apr; 14(2):112-36. PubMed ID: 10782497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.